What is the average price target for INSPIREMD INC (NSPR) stock?
9 analysts have analysed NSPR and the average price target is 5.1 USD. This implies a price increase of 308% is expected in the next year compared to the current price of 1.25.
INSPIREMD INC (NSPR) Forecast, Price Target & Analyst Ratings
NASDAQ:NSPR • US45779A8466
Current stock price
1.25 USD
-0.03 (-2.34%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INSPIREMD INC (NSPR).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 12, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.18
- Revenue Estimate
- 2.752M
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.10
Upside
+ 308.00%
From current price of $1.25 to mean target of $5.10, Based on 9 analyst forecasts
Low
$4.04
Median
$5.10
High
$6.30
Price Target Revisions
1 Month
0.00%
3 Months
25.00%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for NSPR. The average price target is 5.1 USD. This implies a price increase of 308% is expected in the next year compared to the current price of 1.25.
The average price target has been revised upward by 25% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.22%
NSPR was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NSPR.
In the previous month the buy percentage consensus was at a similar level.
NSPR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-05-12 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-12-11 | Lake Street | Initiate | Buy |
| 2024-09-17 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2023-11-02 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-06-12 | Piper Sandler | Initiate | Overweight |
| 2023-05-17 | National Alliance Securities | Maintains | Buy |
| 2023-03-31 | Alliance Global Partners | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 12, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.18
- Revenue Estimate
- 2.752M
- Revenue Q2Q
- 79.99%
- EPS Q2Q
- 16.55%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
14.81%
EPS (1 Month)
0.00%
EPS (3 Months)
12.20%
Next Earnings Summary
NSPR is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.18 USD and the consensus revenue estimate is 2.75M USD.
The next earnings revenue estimate has been revised upward by 14.81% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.205M 20.02% | 7.009M 12.96% | 8.979M 28.11% | 14.185M 57.98% | 27.719M 95.41% | |
| EBITDA YoY % growth | -20.911M -12.91% | -33.223M -58.88% | -49.138M -47.90% | -54.666M -11.25% | -51.478M 5.83% | |
| EBIT YoY % growth | -21.143M -13.00% | -33.503M -58.46% | -49.614M -48.09% | -65.188M -31.39% | -59.49M 8.74% | |
| Operating Margin | -340.74% | -478.00% | -552.56% | -459.55% | -214.62% | |
| EPS YoY % growth | -1.08 53.85% | -0.78 27.78% | -0.79 -1.28% | -0.74 6.18% | -0.62 16.51% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 16.55% | -0.19 28.08% | -0.18 -8.00% | -0.19 -33.57% | -0.08 55.56% | -0.10 45.45% | -0.15 16.67% | -0.22 -20.00% |
| Revenue Q2Q % growth | 2.752M 79.99% | 3.012M 69.40% | 3.713M 47.17% | 4.741M 50.56% | 5.192M 88.66% | 6.038M 100.46% | 10.649M 186.80% | 15.014M 216.68% |
| EBITDA Q2Q % growth | -13.027M -14.65% | -13.289M -3.70% | -14.088M -10.77% | -14.263M -22.87% | -6.847M 47.44% | -8.375M 36.97% | -16.787M -19.16% | -24.844M -74.18% |
| EBIT Q2Q % growth | -15.956M -39.23% | -16.115M -23.78% | -16.663M -27.68% | -16.611M -37.46% | -9.507M 40.42% | -11.045M 31.47% | -19.478M -16.89% | -27.486M -65.47% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
INSPIREMD INC / NSPR Forecast FAQ
What is the next earnings date for NSPR stock?
INSPIREMD INC (NSPR) will report earnings on 2026-05-12.
What are the consensus estimates for INSPIREMD INC (NSPR) next earnings?
The consensus EPS estimate for the next earnings of INSPIREMD INC (NSPR) is -0.18 USD and the consensus revenue estimate is 2.75M USD.
Can you provide the consensus rating for INSPIREMD INC stock?
The consensus rating for INSPIREMD INC (NSPR) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.